Julie So-Young Kim, President and CEO at TAKEDA PHARMACEUTICAL CO LTD (TAK), sold 89,090 shares at $17.10 ($1.5M) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Open-market sale of $1.5M TAK by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.